Boothbay Fund Management, LLC Nektar Therapeutics Put Options Transaction History

Boothbay Fund Management, LLC

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2022 May 16, 2022	SELL	$4.16 - $13.72 $1.4 Million - $4.61 Million	-336,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $3.64 Million - $6.19 Million	336,200 New	336,200 $4.54 Million

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.